| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 10, 2022 | BDSX Biodesix Inc | Hutton Scott59 | President &CEO | Sell | 13,278 | $1.83 | $24,298.74 | -23.2% | +56.3% | -8.1% | |
| May 10, 2022 | BDSX Biodesix Inc | Cowie Robin Harper62 | CFO, Sec'y &Treasurer | Sell | 3,338 | $1.83 | $6,108.54 | -5.4% | +56.3% | -8.1% | |
| May 10, 2022 | BDSX Biodesix Inc | Siurek Ryan H64 | Chief Accounting Officer | Sell | 1,947 | $1.83 | $3,563.01 | -20.8% | +56.3% | -8.1% | |
| May 10, 2022 | BDSX Biodesix Inc | Georgantas Robert William III | Chief Scientific Officer | Sell | 2,004 | $1.83 | $3,667.32 | -9.9% | +56.3% | -8.1% | |
| May 10, 2022 | OPK Opko Health, Inc. | Zerhouni Elias A.50 | Vice Chairman And President | Buy | 89,600 | $2.79 | $250,396.16 | New | -16.4% | -37.5% | |
| May 10, 2022 | BDSX Biodesix Inc | O'Kane Kieran64 | Chief Commercial Officer | Sell | 1,583 | $1.83 | $2,896.89 | -17.2% | +56.3% | -8.1% | |
| May 10, 2022 | BDSX Biodesix Inc | Pestano Gary Anthony65 | Chief Development Officer | Sell | 1,467 | $1.83 | $2,684.61 | -1.7% | +56.3% | -8.1% | |
| May 10, 2022 | WGS Genedx Holdings Corp. | Ro Isaac89 | Chief Financial Officer | Sell | 19,515 | $2.46 | $48,006.90 | -8.8% | +14.0% | -86.1% | |
| May 9, 2022 | CRL Charles River Laboratories International, Inc. | Massaro George66 | Director | Sell | 178 | $230.96 | $41,110.18 | -0.5% | -3.6% | -18.1% | |
| May 4, 2022 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 17,819 | $547.90 | $9,763,008.29 | -0.4% | +4.2% | -2.9% | |
| May 4, 2022 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 2,181 | $562.46 | $1,226,729.59 | -0.2% | +4.2% | -2.9% | |
| May 2, 2022 | TMO Thermo Fisher Scientific Inc. | Spar Debora L54 | Director | Sell | 200 | $544.36 | $108,871.60 | -19.8% | +8.1% | -0.1% | |
| May 2, 2022 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 10,000 | $545.60 | $5,456,028.93 | -0.4% | +8.1% | -0.1% | |
| May 2, 2022 | PSNL Personalis, Inc. | Moore Stephen Michael52 | General Counsel | Sell | 5,733 | $5.53 | $31,703.49 | -7.0% | -37.7% | -62.5% | |
| Apr 29, 2022 | WGS Genedx Holdings Corp. | Casdin Eli50 | Director | Buy | 11,437,500 | $4.00 | $45,750,000.00 | +228.8% | -25.1% | -87.3% | |
| Apr 29, 2022 | WGS Genedx Holdings Corp. | Meister Keith A.63 | Director | Buy | 11,437,500 | $4.00 | $45,750,000.00 | +73.8% | -25.1% | -87.3% | |
| Apr 29, 2022 | WGS Genedx Holdings Corp. | Icahn School Of Medicine At Mount Sinai | 10% Owner | Buy | 6,250,000 | $4.00 | $25,000,000.00 | +7.1% | -25.1% | -87.3% | |
| Apr 29, 2022 | WGS Genedx Holdings Corp. | Bto Sema4 Holdings L.P. | 10% Owner | Buy | 2,500,000 | $4.00 | $10,000,000.00 | +10.0% | -25.1% | -87.3% | |
| Apr 28, 2022 | WGS Genedx Holdings Corp. | Prentice Anthony85 | Chief Product Officer | Sell | 1,691 | $2.18 | $3,687.56 | -14.6% | -30.1% | -87.9% | |
| Apr 28, 2022 | WGS Genedx Holdings Corp. | Clark Daniel Emmett85 | Secretary And General Counsel | Sell | 1,212 | $2.18 | $2,642.64 | -0.4% | -30.1% | -87.9% | |
| Apr 28, 2022 | WGS Genedx Holdings Corp. | White Karen Ann77 | Chief People Officer | Sell | 1,430 | $2.18 | $3,117.69 | -13.1% | -30.1% | -87.9% | |
| Apr 28, 2022 | WGS Genedx Holdings Corp. | Schadt Eric62 | President &Chief R&D Officer | Sell | 35,899 | $2.18 | $78,274.18 | -20.0% | -30.1% | -87.9% | |
| Apr 25, 2022 | DHR Danaher Corp /de/ | Weidemanis Joakim67 | Executive Vice President | Sell | 6,500 | $255.74 | $1,662,277.50 | -7.0% | +5.1% | -10.8% | |
| Apr 25, 2022 | TWST Twist Bioscience Corp | Banyai William81 | See Remarks | Sell | 378 | $33.98 | $12,844.44 | -0.1% | +22.8% | -62.7% | |
| Apr 22, 2022 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 894 | $36.14 | $32,309.61 | -1.4% | +28.1% | +52.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.